An Open-label, Phase 2 Pilot Study on the Efficacy and Safety of Piclidenoson in Patients With Lowe Syndrome

NCT07410455 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Lowe Syndrome

Interventions

DRUG: Piclidenoson

Sponsor

Can-Fite BioPharma